MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-kappaB pathway and down-regulating NLRC4 inflammasome. Dong W, Luo M, Li Y, Chen X, et al. PLoS One 2024;19:e0306137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dong W, Luo M, Li Y, Chen X, et al. MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-kappaB pathway and down-regulating NLRC4 inflammasome. PLoS One 2024;19:e0306137.
PMID: 39052650